We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
ORIGINAL ARTICLES Sequential High-Dose Alkylating Therapy and Stem Cell Support for High-Risk Stage III Breast Cancer.
- Authors
Bou-Khalil, Josette; Rose, Michal; Psyrri, Amanda; Elizabeth D'Andrea, Amanda; Medoff, Erin; Staugaard-Hahn, Carol; Holtkamp, Christine; Gran, Susan; Pezzimente, John; Snyder, Edward; Cooper, Dennis; Haffty, Bruce; Reiss, Michael; Burtness, Barbara
- Abstract
Patients who receive neoadjuvant chemotherapy for locally advanced breast cancer and have four or more ipsilateral axillary lymph nodes involved at surgery are at high risk for recurrence, with a median time to relapse of 18 months. We offered such patients high-dose chemotherapy with stem cell rescue. Patients received cyclophosphamide or paclitaxel and granulocyte colony-stimulating factor (G-CSF) to mobilize stem cells. Melphalan 140 mg/m2 was then given with stem cell rescue. Twenty-four to 35 days later, thiotepa 900 mg/m2 was given with stem cell rescue. Patients with hormone receptor-positive tumors received tamoxifen. We treated 14 patients in this fashion from 1995 to 1998. The mean age was 46.7 years. The majority of cancers were stage IIIB (79%). Thirteen women underwent mastectomy after anthracycline-containing chemotherapy and 50% had more than seven positive lymph nodes. Hospitalization was principally for neutropenic fever. Other morbidities were pneumonitis, cardiomyopathy, and grade 3/4 white blood cell (WBC) toxicity. No patient died of a treatment-related complication. Seven of 14 relapsed at 10, 12, <15, 15, 17, 21, and 36 months, with median follow-up of 26.5 months. Time to relapse in this small series is only modestly improved over historical experience with standard-dose adjuvant chemotherapy. Alternative strategies for treating locally advanced breast cancer should be pursued.
- Subjects
BREAST cancer; DRUG therapy; STEM cells; LYMPH nodes; THERAPEUTICS; DIAGNOSIS
- Publication
Breast Journal, 2003, Vol 9, Issue 6, p472
- ISSN
1075-122X
- Publication type
Article
- DOI
10.1046/j.1524-4741.2003.09604.x